Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

WKSP: April Update

By Thomas Kerr, CFA NASDAQ:WKSP READ THE FULL WKSP RESEARCH REPORT

Benzinga

38 Stocks Moving In Thursday's Mid-Day Session

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) jumped 57.6% to $1.3515. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share.

Benzinga

What Is PayPal 3.0 — And How Does It Affect Investors?

PayPal Holdings Inc (NASDAQ: PYPL) is undertaking several growth initiatives that could shape its future, according to BofA Securities. The PayPal Holdings Analyst: Jason Kupferberg maintained a Neutral rating on PayPal Holdings, with an unchanged price target of $118.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

What Are Whales Doing With Moderna

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

This Is What Whales Are Betting On Tesla

A whale with a lot of money to spend has taken a noticeably bearish stance on Tesla. Looking at options history for Tesla (NASDAQ:TSLA) we detected 596 strange trades.

Benzinga

Analysts Bump Up Costco Price Target Post March Sales Results

Truist analyst Scot Ciccarelli raised the price target on Costco Wholesale Corp (NASDAQ: COST) to $634 from $603 and kept a Buy rating on the shares.

Benzinga

How Is The Market Feeling About Regeneron Pharmaceuticals Inc?

Regeneron Pharmaceuticals Inc's (NASDAQ:REGN) short percent of float has risen 4.85% since its last report. The company recently reported that it has 2.24 million shares sold short, which is 2.16% of all regular shares that are available for trading.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Looking Into Momentus Inc. - Class A Common Stock's Recent Short Interest

Momentus Inc. - Class A Common Stock's (NASDAQ:MNTS) short percent of float has risen 19.09% since its last report. The company recently reported that it has 2.53 million shares sold short, which is 4.99% of all regular shares that are available for trading.

Benzinga

Insurance Stocks Moving In Thursday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Benzinga

FDA Places Partial Hold On Vadadustat Pediatric Studies, Akebia Cuts Over 40% Staff

Battered after a surprising FDA rejection for its lead pipeline program last week, Akebia Therapeutics Inc (NASDAQ:AKBA) has layoffs that are now on the way. In a filing with the SEC, Akebia said the FDA issued a partial clinical hold on the drug's pediatric studies. As a result, Akebia will suspend all vadadustat studies…

Benzinga

Mid-Day Market Update: Dow Tumbles Over 200 Points; Momentus Shares Jump

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Thursday.

Benzinga

AstraZeneca Bets $25M On Preclinical Bispecific Antibody

Harbour BioMed has announced a global out-license agreement with AstraZeneca plc (NASDAQ:AZN) for CLDN18.2xCD3 bispecific antibody (HBM7022). HBM7022 is a novel bispecific antibody generated from HBM's HCAb Based Immune Cell Engagers (HBICE) Platform. HBM7022 is currently in the preclinical stage, which crosslinks tumor cells and T cells by targeting a tumor-associated antigen (Claudin18.2) and…

Benzinga

Trevi Therapeutics Shares Gain On Raising $55M Via Equity

Trevi Therapeutics Inc (NASDAQ: TRVI) has announced a private placement of 4.5 million priced at $1.90 per share and pre-funded warrants to purchase up to 24.4 million shares at $1.899 per warrant.

Benzinga

AngioDynamics Posts Wider Q3 Loss On Higher Costs, Reaffirms FY22 Outlook

AngioDynamics Inc (NASDAQ:ANGO) has reported a Q3 FY22 adjusted EPS of $0.03, ahead of the consensus of $(0.01), and better than the consensus of $0.02 reported a year ago. Q3 sales increased 3.9% Y/Y to $73.97 million, missing the analyst consensus of $76.32 million. Endovascular Therapies net sales increased 14.5% to $38.1…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

JPMorgan Chase Partners With EVgo To Install EV Charging Stations

Chase, the U.S. consumer and commercial banking business of JPMorgan Chase & Co (NYSE:JPM), has partnered with EVgo Inc (NASDAQ:EVGO) to install charging stations. Chase will pilot public fast electric vehicle charging stations across 50 of its U.S. branches beginning in the summer of 2022. The move will support the firm’s aim to expand on-site solar…

Benzinga

Why Grid Dynamics Shares Are Gaining Today

Grid Dynamics Holdings Inc (NASDAQ: GDYN) provided a positive update on its current operations and business continuity efforts in response to the conflict in Ukraine.

Benzinga

Solana NFTs Are Live On OpenSea: Here Are The Details And Some Early Profiled Collections

Less than two weeks after announcing Solana NFTs were coming to NFT marketplace OpenSea, they are officially here and ready to be bought and sold.

Benzinga

Here's Why Analysts Expressed Caution Ahead Of Netflix's Q1

Analysts expressed caution ahead of Netflix Inc (NASDAQ:NFLX) Q1 earnings, highlighting EMEA's churn risk, the company's second-largest region, due to potential consumer spending pressure tied to higher energy costs and broader inflationary pressures and loss of subscribers in Russia. Baird analyst William Power noted that each 10 bps increase in churn could negatively…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Costco Soars Into Blue Skies: Here's How To Trade In All-Time Highs

Costco Wholesale Corporation (NASDAQ: COST) gapped up into blue skies on Thursday and rose about 2% of the open to reach a new all-time high of $603.78. All-time highs generate excitement and interest that can translate into increased buying pressure and above average volume.

Benzinga

Looking At Apple's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bearish stance on Apple. Looking at options history for Apple (NASDAQ:AAPL) we detected 25 strange trades.

Benzinga

Twist Bioscience Inks Antibody Discovery Pact With MediSix Therapeutics

Twist Bioscience Corporation (NASDAQ: TWST) and MediSix Therapeutics have collaborated to discover novel antibodies

Benzinga

Check Out What Whales Are Doing With AMD

Someone with a lot of money to spend has taken a bullish stance on Advanced Micro Devices (NASDAQ:AMD). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Credit Suisse Is Bullish On This Data Center Operator Amid Odds - Read Why

Credit Suisse analyst Sami Badri initiated coverage of Cyxtera Technologies Inc (NASDAQ:CYXT) with an Outperform rating and a $15 price target. The price target implied an upside of 20% from current levels. Cyxtera is a data center operator in the retail colocation segment, previously a part of Lumen's portfolio. Cyxtera's occupancy rate of 70.9% lagged the…

Benzinga

Here's Why JPMorgan Trimmed Apple's Earnings Outlook

JPMorgan analyst Samik Chatterjee sees consumer spending restricting the upside expectations from Apple Inc's (NASDAQ: AAPL) launch of the iPhone SE3 and will likely limit the magnitude of upside to iPhone 13 and App Store revenue in Services. Chatterjee trimmed earnings forecasts for Apple, led by a "modest haircut" to revenue growth estimates for iPhone and…

Benzinga

Housing Beat: Mortgage Rates Keep Climbing; Disney's Affordable Housing Project

Mortgage rates are continuing their upward motion while potential homebuyers and sellers face a shifting housing market and the affordable housing sector welcomes a well-known new participant.

1 … 775 776 777 778

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.